Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients. A Phase I Pilot Study.

NCT05595681 is registered in ClinicalTrials.gov with Cell to Cure ApS as lead sponsor.

NCT NCT05595681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05595681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients. A Phase I Pilot Study.
Lead sponsor
Cell to Cure ApS
Phase
Phase 1
Overall status
Terminated
Start date
December 15, 2022
Completion date
November 28, 2025
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer, mesenchymal stromal cells